The use of selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs) was associated with an increased risk for type 2 diabetes

http://www.endocrinologyadvisor.com/type-2-diabetes/ssri-snri-antidepressants-diabetes-children-adolescents/article/704844/